News & Events

HTG Molecular Announces Amendment to Second Statement of Work with QIAGEN Manchester Limited

TUCSON, Ariz. , Aug. 09, 2018 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc.  (Nasdaq: HTGM) (HTG), a provider of instruments, reagents, and services for molecular profiling applications, today announced that it has entered into an amendment to the second statement of work (“SOW Two”) under

full press release

Posted on:

Return To List

Page last updated